Jefferson Vicente Urvina Muñoz

Jefferson Vicente Urvina Muñoz

Auto-generated profile, based on publicly available information

Jefferson Vicente Urvina Muñoz

Universidad de Guayaquil, Guayaquil, Ecuador

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2024 in Sapienza: International Journal of Interdisciplinary Studies
Verified
Journal Article
Open access
PDF file
JMJefferson Vicente Urvina Muñoz
Jefferson Vicente Urvina Muñoz
ELErika Alejandra Zúñiga San Lucas
Erika Alejandra Zúñiga San Lucas
NVNey Asdrubal Macias Valdez
Ney Asdrubal Macias Valdez
JVJean Pierre Villafuerte
Jean Pierre Villafuerte
CRCristhian Andrés Arroba Riofrio
Cristhian Andrés Arroba Riofrio
Background. Omics technologies, such as genomics, proteomics, metabolomics, and Transcriptomics are being used for identifying biomarkers. These biomarkers are unraveling the molecular mechanisms underlying type 2 diabetes mellitus (T2DM), which can help to promote more personalized treatment strategies and advance our understanding of disease pathogenesis. Omics approaches enable the examination of genetic, protein, metabolic, and gene expression profiles more comprehensively while offering insights into T2DM risk, progression, and potential therapeutic targets. Methods: This review follows a systematic methodology, aimed at evaluating omics technology’s role in diabetes research. Utilizing literature searches, we got an initial pool of 257 studies with a rigorous selection process and narrowed the selection to 10 high-quality studies. Our methodology approach ensured the inclusion of relevant, peer-reviewed articles that contribute significantly to understanding the application of omics technologies in predicting biomarkers for type 2 diabetes. Results: The systematic review identifies ten high-quality studies illuminating substantial omics technology’s role in advancing our understanding of type 2 diabetes (T2D). Collectively, these studies demonstrate how genomics, proteomics, metagenomics, metabolomics, and Transcriptomics have uncovered novel biomarkers and molecular pathways for T2D. Our findings underscore all the omics potentials specifically for developing predictive biomarkers, enhancing diagnostics, and tailoring personalized treatment strategies. Genetic variations, metabolic alterations, and protein and RNA expression profiles were highlighted as key areas where omics technologies offer insights into the pathophysiology and management of T2D.

1 October 2025 in Mediciencias UTA
Verified
Journal Article
Open access
PDF file
JAJavier Aquiles Hidalgo Acosta
Javier Aquiles Hidalgo Acosta
KEKléber Eduardo González Echeverría
Kléber Eduardo González Echeverría
JMJefferson Vicente Urvina Muñoz
Jefferson Vicente Urvina Muñoz
NONatalia Andrea Campos Ordoñez
Natalia Andrea Campos Ordoñez
RTRobert Alexander Vite Tauriz
Robert Alexander Vite Tauriz
DTDoris Sherlene Domo Tomalá
Doris Sherlene Domo Tomalá
La trombectomía mecánica o percutánea es una técnica de neurointervencionismo, que se utiliza en los casos en los que, no se ha logrado realizar trombólisis dentro de las primeras 4,5 horas, convirtiéndose en una terapia estándar para pacientes con ictus isquémico agudo que están discapacitados o presentan contraindicaciones como cirugía reciente, coagulopatía o se encuentran fuera de tiempo de ventana. Los anestésicos tienen efecto sobre el equilibrio entre el consumo y aporte de oxígeno cerebral, por cuanto el manejo anestésico durante la trombectomía mecánica garantiza la seguridad del paciente y el éxito del procedimiento. Objetivo: Determinar los resultados neurológicos, reperfusión exitosa y el manejo anestésico para el accidente cerebrovascular isquémico con trombectomía percutánea. Métodos Criterios de elegibilidad: se seleccionaron 12 ensayos clínicos aleatorizados que cumplieron con la inclusión y fueron analizados. Fuentes de información utilizadas para la búsqueda sistemática según la declaración PRISMA 2020: bases de datos como Embase, CENTRAL y Latindex, con fecha ultima de búsqueda 13 de septiembre 2025. Riesgo de sesgo de los estudios individuales: representada de forma descriptiva en la tabla de resultados. Resultados Se incluyeron 12 estudios clínicos aleatorizados demostrando que, la recuperación funcional se alcanza más rápido con la sedación consciente, presentando un porcentaje mayor de recuperación. Al analizar la reperfusión exitosa en tiempo y recanalización medida por imagen, los resultados favorecen a la anestesia general con significancia estadística, no obstante, la utilización de anestesia general se asocia con menos recuperación neurológica funcional, en comparación con la sedación consciente. Sin embargo, es considerada el procedimiento de elección en pacientes con ACV, puesto que, se consiguen mejores tasas de reperfusión del vaso afecto. Discusión La anestesia general tiene más probabilidades de recanalización exitosa, por lo que, administrar anestesia general presento resultados superiores en recanalización y la sedación consciente en recuperación neurológica funcional inicial, se necesitan más estudios clínicos sobre poblaciones específicas de evento ictus isquémico

1 April 2025 in Mediciencias UTA
Verified
Journal Article
Open access
PDF file
JAJavier Aquiles Hidalgo Acosta
Javier Aquiles Hidalgo Acosta
RGRomina Ivanna Mendoza Granda
Romina Ivanna Mendoza Granda
IQIsrael Luis Villavicencio Quevedo
Israel Luis Villavicencio Quevedo
UVUrvina Muñoz Jefferson Vicente
Urvina Muñoz Jefferson Vicente
WZWagnner Ariol Intriago Zambrano
Wagnner Ariol Intriago Zambrano
Introduction: Neuroinfection is a serious cause of neurological disease, epidemiologically it is estimated that it affects 2.5 million people in the world, at any age, with greater prevalence in regions that lack vaccination programs, such as the African continent specifically in the area called meningitis belt, where there is a high prevalence of the disease. since it is considered a health problem of great relevance worldwide. Objectives: to conduct a systematic review on complications and mortality in neuroinfection. Materials and methods: Databases such as PubMed, Wiley, SciELO, BMC, Europe PMC, Latindex, Google Scholar were searched. Observational studies, multicenter studies, randomized trials, systemic reviews, and meta-analyses were included with the research topic with a total of 50 articles. Results: According to a meta-analysis of 157 656 published cases of bacterial meningitis, the highest case fatality rate was presented by meningitis caused by Listeria monocytogenes with 27%, pneumococci 24%, meningococci 9% and H. influenzae 11%, whereas, the immunization of individuals with risk factors or areas against invasive meningococcal disease caused by Neisseria meningitidis of groups A, C, Y, W and X is a priority. A retrospective study carried out at the Eugenio Espejo Hospital in Quito revealed that 58 patients with HIV and neuroinfection accounted for 13.27% of admissions, the clinical manifestations were characterized by altered state of consciousness in 25.86%, seizures in 20.7%, headache in 15.5%, neurological focality in 39.7% of cases. Conclusions: Neuroinfection is a common pathological state in patients with risk factors or exposed to risk areas where preventive immunization is deficient and represent susceptible populations that can generate infection in the brain, presenting high morbidity and mortality and important neurological sequelae. In our country, the largest number of patients with neuroinfection is expressed by patients suffering from the human immunodeficiency virus

29 February 2024 in International Journal of Medical Science and Dental Health
Verified
Journal Article
Closed access
GRGabriela Patricia Guijarro Reinoso
Gabriela Patricia Guijarro Reinoso
NMNathaly Paola Castro Moscoso
Nathaly Paola Castro Moscoso
PGPaula Doménica Astudillo Goyo
Paula Doménica Astudillo Goyo
BRBryan Steven Pasquel Rodríguez
Bryan Steven Pasquel Rodríguez
JMJefferson Vicente Urvina Muñoz
Jefferson Vicente Urvina Muñoz
UPUniversidad Central del Ecuador Physician
Universidad Central del Ecuador Physician